DSpace JSPUI
DSpace preserves and enables easy and open access to all types of digital content including text, images, moving images, mpegs and data sets
Learn More
Utilizza questo identificativo per citare o creare un link a questo documento:
http://elea.unisa.it/xmlui/handle/10556/4486Record completo di tutti i metadati
| Campo DC | Valore | Lingua |
|---|---|---|
| dcterms.contributor.author | Trapani, Dario | - |
| dcterms.contributor.author | Conforti, Fabio | - |
| dcterms.contributor.author | De Pas, Tommaso | - |
| dc.date.accessioned | 2020-05-25T12:50:45Z | - |
| dc.date.available | 2020-05-25T12:50:45Z | - |
| dcterms.date.issued | 2017 | - |
| dcterms.identifier.citation | Trapani D, Conforti F, De Pas T. Egfr inhibition in a pretreated sacral chordoma: a rolefor erlotinib? Case report and a brief review of literature. Translational Medicine @ UniSa 2017, 16(5): 30-33. | it_IT |
| dcterms.identifier.issn | 2239-9747 | it_IT |
| dcterms.identifier.uri | http://www.translationalmedicine.unisa.it/index | it_IT |
| dcterms.identifier.uri | http://elea.unisa.it:8080/xmlui/handle/10556/4486 | - |
| dcterms.identifier.uri | http://dx.doi.org/10.14273/unisa-2684 | - |
| dc.description.abstract | We describe the case of a 69-year old male with an EGFR- positive Imatinib refractory sacral chordoma with synchronous lung metastases, treated with erlotinib, a first- generation EGFR inhibitor. After disease progression following firstline Imatinib and a combination therapy with everolimus plus metformin, we made a challenge with an EGFR tyrosine kinase inhibitor (EGFR TKI), erlotinib. Despite a brief clinical benefit, the patient presented a rapid clinical deterioration leading to death, after 8 weeks of treatment. | it_IT |
| dcterms.format.extent | P. 30-33 | it_IT |
| dc.language.iso | en | it_IT |
| dcterms.source | UniSa. Sistema Bibliotecario di Ateneo | it_IT |
| dcterms.subject | Chordoma | it_IT |
| dcterms.subject | Erlotinib | it_IT |
| dcterms.subject | Imatinib refractory | it_IT |
| dcterms.subject | Sacral tumor | it_IT |
| dcterms.title | Egfr inhibition in a pretreated sacral chordoma: a rolefor erlotinib? Case report and a brief review of literature | it_IT |
| dcterms.type | Article | it_IT |
| È visualizzato nelle collezioni: | Translational Medicine @ UniSa. Volume 16 (jen. - jun. 2017) | |
File in questo documento:
Non ci sono file allegati a questo documento
Tutti i documenti archiviati in DSpace sono protetti da copyright. Tutti i diritti riservati.